Rexahn Receives Notice of Allowance for US Patent Covering RX-3117 Use in a Broad Range of Tumor Types Associated Press
ROCKVILLE, Md., Feb. 04, 2019 (GLOBE NEWSWIRE) — Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical-stage biopharmaceutical company …